A comprehensive US-India trade framework reduces effective tariffs to 18%, down from approximately 50%, representing a major breakthrough for Indian exporters. The agreement provides zero-duty access for pharmaceuticals, gems, and textiles, unlocking market access valued at ₹2,72,000+ crore.
Trade Deal Structure
Effective Tariff Rate: 18%
The negotiated tariff rate of 18% provides substantial cost advantages for Indian exporters competing in the US market. This rate is significantly lower than rates offered to regional competitors, positioning India favorably in global trade.
Zero-Duty Sectors
Three critical sectors receive duty-free access to the US market:
– Pharmaceuticals
– Gems & jewellery
– Textiles
Competitive Advantage
India has negotiated better rates than Vietnam (20%) and Bangladesh (20%), strengthening competitive positioning for Indian manufacturers in the US market.
Strategic Implications
The deal removes trade war uncertainty that had constrained business planning and investment decisions. This economic stability for the manufacturing sector enables long-term capacity planning and investment decisions. Export competitiveness is revived for textiles and pharma sectors, while manufacturing margins improve across affected industries.
The breakthrough enables long-term business planning and supports India’s manufacturing competitiveness in a complex global trade environment.
Leave a comment